Cargando…
iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
BACKGROUND: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site an...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044289/ https://www.ncbi.nlm.nih.gov/pubmed/21342564 http://dx.doi.org/10.1186/1471-2105-12-S1-S33 |
_version_ | 1782198711917477888 |
---|---|
author | Hsu, Kai-Cheng Chen, Yen-Fu Lin, Shen-Rong Yang, Jinn-Moon |
author_facet | Hsu, Kai-Cheng Chen, Yen-Fu Lin, Shen-Rong Yang, Jinn-Moon |
author_sort | Hsu, Kai-Cheng |
collection | PubMed |
description | BACKGROUND: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. RESULTS: We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. CONCLUSIONS: We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. |
format | Text |
id | pubmed-3044289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30442892011-02-25 iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis Hsu, Kai-Cheng Chen, Yen-Fu Lin, Shen-Rong Yang, Jinn-Moon BMC Bioinformatics Research BACKGROUND: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. RESULTS: We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. CONCLUSIONS: We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. BioMed Central 2011-02-15 /pmc/articles/PMC3044289/ /pubmed/21342564 http://dx.doi.org/10.1186/1471-2105-12-S1-S33 Text en Copyright ©2011 Hsu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hsu, Kai-Cheng Chen, Yen-Fu Lin, Shen-Rong Yang, Jinn-Moon iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title_full | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title_fullStr | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title_full_unstemmed | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title_short | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
title_sort | igemdock: a graphical environment of enhancing gemdock using pharmacological interactions and post-screening analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044289/ https://www.ncbi.nlm.nih.gov/pubmed/21342564 http://dx.doi.org/10.1186/1471-2105-12-S1-S33 |
work_keys_str_mv | AT hsukaicheng igemdockagraphicalenvironmentofenhancinggemdockusingpharmacologicalinteractionsandpostscreeninganalysis AT chenyenfu igemdockagraphicalenvironmentofenhancinggemdockusingpharmacologicalinteractionsandpostscreeninganalysis AT linshenrong igemdockagraphicalenvironmentofenhancinggemdockusingpharmacologicalinteractionsandpostscreeninganalysis AT yangjinnmoon igemdockagraphicalenvironmentofenhancinggemdockusingpharmacologicalinteractionsandpostscreeninganalysis |